This company, founded in 2012, specializes in developing and commercializing innovative medical device therapies for patients with hypervascular tumors. With a diverse team of experts in various fields, they aim to improve treatment outcomes and enhance the lives of patients. Their focus is on personalized healthcare in oncology, utilizing advanced technology and a multidisciplinary approach.